Organoid-based Functional Precision Therapy for Advanced Breast Cancer

NCT06102824 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

252

Enrollment

OTHER

Sponsor class

Conditions

HER2-negative Breast Cancer
Advanced Breast Cancer

Interventions

DRUG: Organoid-guided treatment
DRUG: Taxane
DRUG: Capecitabine
DRUG: Gemcitabine
DRUG: Vinorelbine
DRUG: Eribulin
DRUG: Anthracycline
DRUG: Carboplatin
DRUG: Utidelone
DRUG: Trastuzumab deruxtecan
DRUG: Sacituzumab govitecan

Sponsor

Guangdong Provincial People's Hospital

Collaborators

[object Object]
[object Object]
[object Object]